Skip to main content
. 2021 Aug 2;47(1):225–246. doi: 10.1038/s41386-021-01101-7

Fig. 3. Summary of findings in rodents subject to chronic stress as adults revealing (i) structural and physiological changes in the medial prefrontal cortex (medial PFC) and orbitofrontal cortex (OFC), (ii) associated behavioral changes and (iii) interventions within the medial PFC and OFC that ameliorate the behavioral changes.

Fig. 3

Both (i) and (iii) implicate dysregulation within medial PFC and OFC in relation to the behavioral changes associated with chronic stress. ieg immediate early gene, CB1 endocannabinoid presynaptic receptor, DA dopamine, DBS deep brain stimulation, Discrim Rev discrimination reversal task, DMN default mode network, FST forced swim test, LTD long-term depression, MDThal mediodorsal thalamus, NAccumbens nucleus accumbens, PV parvalbumin neurons, SA social avoidance (interaction) test, SPT sucrose preference test. 1. Cook, S.C. & Wellman, C.L. J. Neurobiol. 60, 236–248 (2004). 2. Radley, J.J. et al. Exp. Neurol. 196, 199–203 (2005). 3. Liston, C. et al. J. Neurosci. 26, 7870–7874 (2006). 4. Dias-Ferreira, E. et al. Science (80-.). 325, 621–625 (2009). 5. Covington, H.E. et al. J. Neurosci. 30, 16082–16090 (2010). 6. Lehmann, M.L., Weigel, T.K., Elkahloun, A.G. & Herkenham M. Sci. Rep. 7, 46548. 7. Covington, H.E., Maze, I., Vialou, V. & Nestler, E.J. Neuroscience 298, 329–335 (2015). 8. Kumar, S. et al. Nat. Commun. 5, 1–9 (2014). 9. McLaughlin, R.J. et al. Behav. Brain Res. 237, 333–337 (2013). 10. Perova, Z., Delevich, K. & Li, B. J. Neurosci. 35, 3201–3206 (2015). 11. Vialou, V. et al. J. Neurosci. 34, 3878–3887 (2014). 12. Spring, M.G. et al. J. Neurosci. JN-RM-1869-20 (2021). 13. Xu, C. et al. Neuropharmacology 109, 7–17 (2016). 14. Gourley, S.L., Swanson, A.M. & Koleske, A.J. J. Neurosci. 33, 3107–3112 (2013). 15. Miguel-Hidalgo, J.J., Moulana, M., Deloach, P.H. & Rajkowska, G. Chronic Stress (Thousand Oaks, Calif.) 2, 247054701881418 (2018). 16. Lapiz-Bluhm, M.D.S., Soto-Piña, A.E., Hensler, J.G. & Morilak, D.A. Psychopharmacology (Berl). 202, 329–341 (2009). 17. Henckens, M.J.A.G. et al. Neuroimage 105, 312–322 (2015). 18. Grandjean, J. et al. Neuroimage 142, 544–552 (2016). 19. Gururajan, A., Reif, A., Cryan, J.F. & Slattery, D.A. Nat. Rev. Neurosci. 20, 686–701 (2019). 20. Willner, P. Neurobiol. Stress 6, 78–93 (2017). 21. Mizoguchi, K. et al. J. Neurosci. 20, 1568–1574 (2000). 22. Papciak, J., Popik, P., Fuchs, E. & Rygula, R. Behav. Brain Res. 256, 305–310 (2013). 23. Hamani, C. et al. Biol. Psychiatry 71, 30–35 (2012). 24. Jett, J.D. & Morilak, D.A. Neuropsychopharmacology 38, 585–595 (2013). 25. Kumar, S. et al. J. Neurosci. 33, 1116–1129 (2013). 26. Moreines, J.L., Owrutsky, Z.L. & Grace, A.A. Neuropsychopharmacology 42, 904–913 (2017). 27. Nawreen, N. et al. eNeuro 7, (2020). 28. Adler, S.M., Girotti, M. & Morilak, D.A. Neurobiol. Stress 13, 100258 (2020). 29. Patton, M.S., Lodge, D.J., Morilak, D.A. & Girotti, M. Neuropsychopharmacology 42, 1220–1230 (2017).